IntegraGen
Genomics specialist providing analyses & SaaS for cancer/rare diseases to researchers & labs.
ALINT | PA
Overview
Corporate Details
- ISIN(s):
- FR0010908723
- LEI:
- 969500CQD8K0BUIGDH55
- Country:
- France
- Address:
- 5 RUE HENRI DESBRUERES, 91000 EVRY-COURCOURONNES
- Website:
- https://integragen.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
IntegraGen, an OncoDNA group company, is a genomics specialist focused on translating molecular research into clinical practice. The company provides services in cancer genomics and rare genetic diseases, offering interpretable genomic analyses for academic researchers, private laboratories, and life sciences companies. Its core activities include decoding the human genome, identifying genetic biomarkers, and developing and commercializing molecular diagnostic tests. IntegraGen leverages its expertise in high-throughput sequencing and bioinformatics to provide solutions, including proprietary Software-as-a-Service (SaaS) tools designed for the interpretation of large-scale genomic data.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for IntegraGen and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-04-29 18:00 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 351.8 KB | |
| 2025-04-29 18:00 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 356.4 KB | |
| 2025-01-15 18:44 |
Earnings Release
Inside Information / Information on annual revenues
|
English | 214.4 KB | |
| 2025-01-15 18:44 |
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
|
French | 215.6 KB | |
| 2024-10-17 18:29 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 343.2 KB | |
| 2024-10-17 18:29 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 398.7 KB | |
| 2024-07-18 18:44 |
Earnings Release
Inside Information / Other news releases
|
English | 270.7 KB | |
| 2024-07-18 18:44 |
Earnings Release
Informations privilégiées / Autres communiqués
|
French | 268.3 KB | |
| 2024-04-18 18:00 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 372.7 KB | |
| 2024-04-18 18:00 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 419.4 KB | |
| 2024-01-16 17:45 |
Earnings Release
Inside Information / Information on annual revenues
|
English | 307.9 KB | |
| 2024-01-16 17:45 |
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
|
French | 269.3 KB | |
| 2023-10-19 18:15 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 332.6 KB | |
| 2023-07-13 07:30 |
Earnings Release
Inside Information / Other news releases
|
English | 204.7 KB | |
| 2023-04-24 18:00 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 330.5 KB |
Automate Your Workflow. Get a real-time feed of all IntegraGen filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for IntegraGen via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
